Lyric Pharmaceuticals' Series A - II Round

Lyric Pharmaceuticals raised a round of funding on April 24, 2017.

Lyric is a clinical stage company developing novel gastrointestinal therapeutics for unmet medical needs in the hospital setting.…

Articles about Lyric Pharmaceuticals' Series A - II Round: